[The use of cavinton in the therapy of cognitive disorders in patients with discirculatory encephalopathy].
Odinak
M M
MM
Lobzin
V Iu
VIu
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002561:Cerebrovascular Disorders / Q000150:complications* / Q000000981:diagnostic imaging / Q000503:physiopathology; D003071:Cognition / Q000187:drug effects*; D003072:Cognition Disorders / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D004305:Dose-Response Relationship, Drug; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007262:Infusions, Intravenous; D008297:Male; D008875:Middle Aged; D018697:Nootropic Agents / Q000008:administration & dosage*; D016896:Treatment Outcome; D017585:Ultrasonography, Doppler, Transcranial; D014748:Vinca Alkaloids / Q000008:administration & dosage*
D018697:Nootropic Agents; D014748:Vinca Alkaloids; C013983:vinpocetine